Identifying residual hotspots and mapping lower respiratory infection morbidity and mortality in African children from 2000 to 2017
- PMID: 31570869
- PMCID: PMC6877470
- DOI: 10.1038/s41564-019-0562-y
Identifying residual hotspots and mapping lower respiratory infection morbidity and mortality in African children from 2000 to 2017
Abstract
Lower respiratory infections (LRIs) are the leading cause of death in children under the age of 5, despite the existence of vaccines against many of their aetiologies. Furthermore, more than half of these deaths occur in Africa. Geospatial models can provide highly detailed estimates of trends subnationally, at the level where implementation of health policies has the greatest impact. We used Bayesian geostatistical modelling to estimate LRI incidence, prevalence and mortality in children under 5 subnationally in Africa for 2000-2017, using surveys covering 1.46 million children and 9,215,000 cases of LRI. Our model reveals large within-country variation in both health burden and its change over time. While reductions in childhood morbidity and mortality due to LRI were estimated for almost every country, we expose a cluster of residual high risk across seven countries, which averages 5.5 LRI deaths per 1,000 children per year. The preventable nature of the vast majority of LRI deaths mandates focused health system efforts in specific locations with the highest burden.
Conflict of interest statement
This study was funded by the Bill & Melinda Gates Foundation. Otherwise, the funders of the study had no role in the study design, data collection, data analysis, data interpretation, writing of the final report or decision to publish. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Figures
References
-
- Troeger C, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 2018;18:1191–1210. doi: 10.1016/S1473-3099(18)30310-4. - DOI - PMC - PubMed
-
- Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst. Rev. 2003;4:CD001729. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
